[1]
C. Sartor, “Recurrent gastrointestinal hemorrhage in treatment with dasatinib in a patient showing SMAD4 mutation with acute lymphoblastic leukemia Philadelphia positive and juvenile polyposis hereditary hemorrhagic telangiectasia syndrome”, Hematol Rep, vol. 5, no. 2, p. e7, Jul. 2013.